Cantor Fitzgerald Reiterates Overweight on Tenet Healthcare, Maintains $168 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Tenet Healthcare (NYSE:THC) and maintained a price target of $168.
August 19, 2024 | 3:41 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald has reiterated its Overweight rating on Tenet Healthcare, maintaining a price target of $168. This suggests confidence in the company's performance and potential for stock price appreciation.
The reiteration of an Overweight rating and a maintained price target of $168 by a reputable analyst indicates a positive outlook for Tenet Healthcare. This can lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100